ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Breast Cancer
Endometrial Cancer
Ovarian Cancer
Adenocarcinoma

Prostate Cancer trials near Pittsburgh, PA, USA:

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Pittsburgh, Pennsylvania, United States and 22 other locations

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Active, not recruiting
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

Pittsburgh, Pennsylvania, United States and 29 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

Pittsburgh, Pennsylvania, United States and 22 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Pittsburgh, Pennsylvania, United States and 194 other locations

The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...

Enrolling
Prostate Cancer
Drug: AMG 509
Drug: Abiraterone

Phase 1

Amgen
Amgen

Pittsburgh, Pennsylvania, United States and 54 other locations

with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Pittsburgh, Pennsylvania, United States and 53 other locations

therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide 160 mg
Drug: Olaparib 400 mg

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Pittsburgh, Pennsylvania, United States and 24 other locations

has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC).The hypothesis for this trial is that caboz...

Enrolling
Prostate Cancer
Drug: Cabozantinib

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

Pittsburgh, Pennsylvania, United States and 3 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 378 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: Leuprolide acetate

Phase 2

Astellas
Astellas

Pittsburgh, Pennsylvania, United States and 235 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems